ID

17653

Descripción

Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc ( OSI Pharmaceuticals ) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part: Withdrawal of Consent

Link

https://clinicaltrials.gov/ct2/show/NCT00373425

Palabras clave

Versiones (2)
  1. 2/8/16 2/8/16 -
  2. 27/9/16 27/9/16 -
Subido en

27 de septiembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425

Inglés

Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 formularios  
Withdrawal of Treatment Consent
Descripción

Withdrawal of Treatment Consent

Withdrawal of Treatment Consent: Not Applicable
Descripción

Withdrawal of Treatment Consent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0087111
Patient withdrew treatment consent during the study. Date:
Descripción

Date Consent Withdrawn

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
Withdrawal of Tissue Consent
Descripción

Withdrawal of Tissue Consent

Withdrawal of Tissue Consent: Not Applicable
Descripción

Withdrawal of Tissue Consent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0475358
Patient withdrew tumor tissue consent during the study. Date:
Descripción

Date Consent Withdrawn

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
Withdrawal of Optional Research Blood Sample Consent
Descripción

Withdrawal of Optional Research Blood Sample Consent

Withdrawal of Optional Research Blood Sample Consent: Not Applicable
Descripción

Withdrawal of Optional Research Blood Sample Consent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0178913
Patient withdrew optional blood sample consent during the study. Date:
Descripción

Date Consent Withdrawn

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
Investigator Signature
Descripción

Investigator Signature

Investigator's Signature
Descripción

Investigator Signature

Tipo de datos

text

Alias
UMLS CUI [1]
C2346576
Signature Date
Descripción

Signature date

Tipo de datos

date

Alias
UMLS CUI [1]
C0807937
Volver a la parte superior de la página

Similar models

Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Withdrawal of Treatment Consent
Withdrawal of Treatment Consent
Item
Withdrawal of Treatment Consent: Not Applicable
boolean
C0021430 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Date Consent Withdrawn
Item
Patient withdrew treatment consent during the study. Date:
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Withdrawal of Tissue Consent
Withdrawal of Tissue Consent
Item
Withdrawal of Tissue Consent: Not Applicable
boolean
C0021430 (UMLS CUI [1,1])
C0475358 (UMLS CUI [1,2])
Date Consent Withdrawn
Item
Patient withdrew tumor tissue consent during the study. Date:
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Withdrawal of Optional Research Blood Sample Consent
Withdrawal of Optional Research Blood Sample Consent
Item
Withdrawal of Optional Research Blood Sample Consent: Not Applicable
boolean
C0021430 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
Date Consent Withdrawn
Item
Patient withdrew optional blood sample consent during the study. Date:
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Investigator Signature
Investigator Signature
Item
Investigator's Signature
text
C2346576 (UMLS CUI [1])
Signature date
Item
Signature Date
date
C0807937 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial